Routine Health Screening Global Market Report 2025

Description

Routine health screening involves regular medical tests and check-ups designed to detect potential health issues before symptoms arise. These screenings are essential for monitoring overall health, identifying risk factors, and preventing serious conditions such as heart disease, diabetes, or cancer. Recommendations for screenings are typically based on factors such as age, gender, and health history, and they play a crucial role in maintaining long-term health and well-being.

The main types of routine health screenings include blood glucose tests, kidney function tests, bone profile tests, electrolyte tests, liver function tests, lipid profile tests, and others. A blood glucose test measures the level of glucose (sugar) in the blood to detect or manage diabetes. Samples for these tests can be obtained from blood, urine, serum, saliva, and other sources. Technologies used in these screenings include quantitative polymerase chain reaction (QPCR), quantitative fluorescence in situ hybridization (Q-FISH), immunoassays, medical imaging, single telomere length analysis (STELA), and others. Sample collection sites for these tests may include hospitals, homes, diagnostic laboratories, offices, and other locations.

The routine health screening market research report is one of a series of new reports from The Business Research Company that provides routine health screening market statistics, including routine health screening industry global market size, regional shares, competitors with a routine health screening market share, detailed routine health screening market segments, market trends and opportunities, and any further data you may need to thrive in the routine health screening industry. This routine health screening market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The routine health screening market size has grown strongly in recent years. It will grow from $54.28 billion in 2024 to $58.45 billion in 2025 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to increasing awareness of preventive healthcare, the rising prevalence of chronic diseases, growing government initiatives for early disease detection, the aging global population, and the expansion of healthcare infrastructure.

The routine health screening market size is expected to see strong growth in the next few years. It will grow to $77.76 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to the growing adoption of personalized medicine, increasing focus on chronic disease management, expansion of healthcare access in emerging markets, rising healthcare spending, and greater public and private investment in preventive health programs. Major trends in the forecast period include the integration of artificial intelligence for improved diagnostic accuracy, expansion of health screening services through telemedicine platforms, heightened focus on preventive care driven by public health initiatives, enhanced patient engagement through mobile health apps and digital health platforms, and the development of advanced biomarker-based screening technologies.

The growing awareness of preventive healthcare is expected to boost the routine health screenings market in the future. Preventive healthcare involves practices and measures aimed at preventing diseases and health conditions through early detection, lifestyle changes, and proactive interventions. Increased awareness of preventive healthcare is due to its advantages in early disease detection, improved health outcomes, and cost savings, driven by enhanced public education and medical advancements. Routine health screenings support preventive healthcare by identifying potential health issues early, enabling timely interventions, and reducing the risk of severe diseases. For example, the National Health Service (NHS) reported in May 2023 that 2,302,400 diagnostic tests were conducted in March 2023, an increase of 223,100 tests compared to March 2022. By the end of March 2023, the number of patients waiting for a key diagnostic test had risen to 1,628,300, an increase of 59,400 from March 2022. This indicates that the rising awareness of preventive healthcare is driving growth in the routine health screenings market.

Leading companies in the routine health screenings market are focusing on developing advanced solutions, such as lung cancer screening tests, to gain a competitive advantage. These tests are designed to detect lung cancer early in individuals at high risk, even before symptoms appear. For instance, in October 2023, DELFI Diagnostics, Inc., a U.S.-based diagnostic technology company, launched the FirstLook Lung test, an innovative blood test aimed at improving lung cancer screening. FirstLook Lung uses fragmentomics to analyze patterns in cell-free DNA (cfDNA) from blood samples and employs advanced machine learning to distinguish between cancerous and non-cancerous patterns. With a 99.7% negative predictive value (NPV), the test accurately identifies potential lung cancer cases while reducing the need for unnecessary low-dose CT (LDCT) scans. FirstLook Lung is integrated into routine blood tests to improve screening rates, especially among underserved populations, and features a scalable whole-genome machine-learning platform that could potentially expand into other cancers and treatment monitoring globally.

In March 2024, Laboratory Corporation of America Holdings, a U.S.-based healthcare and diagnostics company, acquired BioReference Health from OPKO Health, Inc. for $237.5 million. This acquisition is intended to enhance Labcorp's capabilities and access in routine health screening. BioReference Health, a U.S.-based diagnostic laboratory company, offers testing services, including routine health screenings, oncology, urology, and reproductive and women's health tests.

Major companies operating in the routine health screening market are Roche Holding AG, Thermo Fisher Scientific Inc., Siemens Healthineers, Laboratory Corporation, Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Sonic Healthcare Limited, Hologic Inc., Illumina Inc., SYNLAB International GmbH, Sysmex Corporation, QIAGEN N.V., Exact Sciences Corporation, RadNet Inc., Opko Health Inc., UNILABS, Amedes Holding GmbH, Natera Inc., Grail Inc., Trinity Biotech PLC, Cerba HealthCare S.A.S., Quidel Corporation, Innova Medical Group

North America was the largest region in the routine health screening market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the routine health screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the routine health screening market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The routine health screening market consists of revenues earned by entities by providing services such as health assessments, screening procedures, consultations, telehealth screenings, and corporate wellness programs. The market value includes the value of related goods sold by the service provider or included within the service offering. The routine health screening also includes sales of diagnostic test kits, medical devices, wearable health devices, and laboratory testing supplies. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Routine Health Screening Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on routine health screening market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for routine health screening ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The routine health screening market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Test Type: Blood Glucose Test; Kidney Function Test; Bone Profile Test; Electrolyte Test; Liver Function Test; Lipid Profile Test; Other Test Types
2) By Sample Type: Blood; Urine; Serum; Saliva; Other Sample Types
3) By Technology: Quantitative Polymerase Chain Reaction (QPCR); Quantitative Fluorescence In Situ Hybridization (Q-FISH); Immunoassays; Medical Imaging; Single Telomere Length Analysis (STELA); Other Technologies
4) By Sample Collection Sites: Hospitals; Homes; Diagnostic Laboratories; Offices; Other Sample Collection Sites
Subsegments:
1) By Blood Glucose Test: Fasting Blood Glucose Test; HbA1c Test; Continuous Glucose Monitoring
2) By Kidney Function Test: Serum Creatinine Test; Blood Urea Nitrogen (BUN) Test; Urinalysis
3) By Bone Profile Test: Serum Calcium Test; Phosphate Test; Bone Mineral Density (BMD) Test
4) By Electrolyte Test: Serum Sodium Test; Serum Potassium Test; Serum Chloride Test
5) By Liver Function Test: Alanine Aminotransferase (ALT) Test; Aspartate Aminotransferase (AST) Test; Bilirubin Test
6) By Lipid Profile Test: Total Cholesterol Test; Low-Density Lipoprotein (LDL) Test; High-Density Lipoprotein (HDL) Test
7) By Other Test Types: Thyroid Function Test; Complete Blood Count (CBC); Prostate-Specific Antigen (PSA) Test
Companies Mentioned: Roche Holding AG; Thermo Fisher Scientific Inc.; Siemens Healthineers; Laboratory Corporation; Quest Diagnostics Incorporated
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r33548

1. Executive Summary

2. Routine Health Screening Market Characteristics

3. Routine Health Screening Market Trends And Strategies

4. Routine Health Screening Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Routine Health Screening Growth Analysis And Strategic Analysis Framework

5.1. Global Routine Health Screening PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Routine Health Screening Market Growth Rate Analysis
5.4. Global Routine Health Screening Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Routine Health Screening Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Routine Health Screening Total Addressable Market (TAM)

6. Routine Health Screening Market Segmentation

6.1. Global Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Blood Glucose Test
Kidney Function Test
Bone Profile Test
Electrolyte Test
Liver Function Test
Lipid Profile Test
Other Test Types
6.2. Global Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Blood
Urine
Serum
Saliva
Other Sample Types
6.3. Global Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Quantitative Polymerase Chain Reaction (QPCR)
Quantitative Fluorescence In Situ Hybridization (Q-FISH)
Immunoassays
Medical Imaging
Single Telomere Length Analysis (STELA)
Other Technologies
6.4. Global Routine Health Screening Market, Segmentation By Sample Collection Sites, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Homes
Diagnostic Laboratories
Offices
Other Sample Collection Sites
6.5. Global Routine Health Screening Market, Sub-Segmentation Of Blood Glucose Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Fasting Blood Glucose Test
HbA1c Test
Continuous Glucose Monitoring
6.6. Global Routine Health Screening Market, Sub-Segmentation Of Kidney Function Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Serum Creatinine Test
Blood Urea Nitrogen (BUN) Test
Urinalysis
6.7. Global Routine Health Screening Market, Sub-Segmentation Of Bone Profile Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Serum Calcium Test
Phosphate Test
Bone Mineral Density (BMD) Test
6.8. Global Routine Health Screening Market, Sub-Segmentation Of Electrolyte Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Serum Sodium Test
Serum Potassium Test
Serum Chloride Test
6.9. Global Routine Health Screening Market, Sub-Segmentation Of Liver Function Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Alanine Aminotransferase (ALT) Test
Aspartate Aminotransferase (AST) Test
Bilirubin Test
6.10. Global Routine Health Screening Market, Sub-Segmentation Of Lipid Profile Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Total Cholesterol Test
Low-Density Lipoprotein (LDL) Test
High-Density Lipoprotein (HDL) Test
6.11. Global Routine Health Screening Market, Sub-Segmentation Of Other Test Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Thyroid Function Test
Complete Blood Count (CBC)
Prostate-Specific Antigen (PSA) Test

7. Routine Health Screening Market Regional And Country Analysis

7.1. Global Routine Health Screening Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Routine Health Screening Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Routine Health Screening Market

8.1. Asia-Pacific Routine Health Screening Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Routine Health Screening Market

9.1. China Routine Health Screening Market Overview
9.2. China Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Routine Health Screening Market

10.1. India Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Routine Health Screening Market

11.1. Japan Routine Health Screening Market Overview
11.2. Japan Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Routine Health Screening Market

12.1. Australia Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Routine Health Screening Market

13.1. Indonesia Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Routine Health Screening Market

14.1. South Korea Routine Health Screening Market Overview
14.2. South Korea Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Routine Health Screening Market

15.1. Western Europe Routine Health Screening Market Overview
15.2. Western Europe Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Routine Health Screening Market

16.1. UK Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Routine Health Screening Market

17.1. Germany Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Routine Health Screening Market

18.1. France Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Routine Health Screening Market

19.1. Italy Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Routine Health Screening Market

20.1. Spain Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Routine Health Screening Market

21.1. Eastern Europe Routine Health Screening Market Overview
21.2. Eastern Europe Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Routine Health Screening Market

22.1. Russia Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Routine Health Screening Market

23.1. North America Routine Health Screening Market Overview
23.2. North America Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Routine Health Screening Market

24.1. USA Routine Health Screening Market Overview
24.2. USA Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Routine Health Screening Market

25.1. Canada Routine Health Screening Market Overview
25.2. Canada Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Routine Health Screening Market

26.1. South America Routine Health Screening Market Overview
26.2. South America Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Routine Health Screening Market

27.1. Brazil Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Routine Health Screening Market

28.1. Middle East Routine Health Screening Market Overview
28.2. Middle East Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Routine Health Screening Market

29.1. Africa Routine Health Screening Market Overview
29.2. Africa Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Routine Health Screening Market Competitive Landscape And Company Profiles

30.1. Routine Health Screening Market Competitive Landscape
30.2. Routine Health Screening Market Company Profiles
- 30.2.1. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Laboratory Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis

31. Routine Health Screening Market Other Major And Innovative Companies

31.1. Eurofins Scientific SE
31.2. Agilent Technologies Inc.
31.3. Sonic Healthcare Limited
31.4. Hologic Inc.
31.5. Illumina Inc.
31.6. SYNLAB International GmbH
31.7. Sysmex Corporation
31.8. QIAGEN N.V.
31.9. Exact Sciences Corporation
31.10. RadNet Inc.
31.11. Opko Health Inc.
31.12. UNILABS
31.13. Amedes Holding GmbH
31.14. Natera Inc.
31.15. Grail Inc.

32. Global Routine Health Screening Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Routine Health Screening Market

34. Recent Developments In The Routine Health Screening Market

35. Routine Health Screening Market High Potential Countries, Segments and Strategies

35.1 Routine Health Screening Market In 2029 - Countries Offering Most New Opportunities
35.2 Routine Health Screening Market In 2029 - Segments Offering Most New Opportunities
35.3 Routine Health Screening Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer
250423_r33548_Routine_Health_Screening_GMR_2025